Evaluation of comparison between Remifentanil infusion and single dose intravenous Hydralazine + Propranolol administration to provide controlled hypotension in patients undergoing Rhino plastic surgery in khalili hospital during 2014-2015

Phase 2

• Conditions: Hypertension.; Hypertensive diseases; I10-I15

• Registration Number: IRCT2015101522173N2
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Inclusion criterion: all patients in the range of 20-40 years old with class I ASA.
Exclusion criteria: patients in class II & III ASA; recent (the last 3 months) general anesthesia record; drug abuse; history of allergy to Propranolol or Hydralazine or Remifentanil; high blood pressure; cardiovascular diseases should be eliminated.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: Before intervention, during intervention, after intervention. Method of measurement: In terms of mmHg, using a Mercury sphygmomanometer.

Secondary Outcome Measures

Name	Time	Method
Bleeding during surgery. Timepoint: After intervention. Method of measurement: According to surgeon report.